Influence of Diosmin Treatment on the Level of Oxidative Stress Markers in Patients with Chronic Venous Insufficiency

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="6"><hr/></td></tr><tr class="thead"><td class="align_left"></td><td class="align_center">8-iso-15(R)-PGF2<i>α</i></td><td class="align_center">8-iso-PGF2<i>α</i></td><td class="align_center">11<i>β</i>-PGF2<i>α</i></td><td class="align_center">15(R)-PGF2<i>α</i></td><td class="align_center">Total</td></tr><tr><td class="thead-hr" colspan="6"><hr/></td></tr><tr><td class="align_left">T<sub>0</sub></td><td class="align_center">3.09</td><td class="align_center">6.61</td><td class="align_center">10.54</td><td class="align_center">19.41</td><td class="align_center">39.65</td></tr><tr><td class="align_left">T<sub>3m</sub></td><td class="align_center">4.28</td><td class="align_center">5.91</td><td class="align_center">1.29</td><td class="align_center">12.50</td><td class="align_center">23.97</td></tr><tr class="table-tr"><td colspan="6"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The level of isoprostanes (pg/ml) in patients before (T<sub>0</sub>) and after 3 months of treatment with diosmin (T<sub>3m</sub>).</div>

Oxidative Medicine and Cellular Longevity

tab2

Table 2

Table 2: Influence of Diosmin Treatment on the Level of Oxidative Stress Markers in Patients with Chronic Venous Insufficiency 